ArticleFrontiers in microbiology2026
Chicken caspase-3 promotes IBDV replication via the cleavage of IRF7.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infectious bursal disease virus (IBDV) is a highly contagious pathogen that causes severe immunosuppression in chickens, leading to significant economic losses. While apoptosis is a critical host defense mechanism, many viruses exploit it to enhance replication. Here, we demonstrate that IBDV infection induces caspase-dependent apoptosis and that the executioner caspase, Caspase-3, is activated to promote viral replication. Mechanistically, we identify a novel immune evasion strategy: Caspase-3 directly cleaves and degrades interferon regulatory factor 7 (IRF7), a key transcriptional activator of the type I interferon (IFN-β) pathway. This cleavage potently suppresses the host antiviral innate immune response. Furthermore, Caspase-3 activity exacerbates IBDV-induced apoptosis. Consequently, pharmacological inhibition of Caspase-3 significantly reduced viral load and apoptosis, whereas its overexpression produced opposite effects. Our findings reveal that IBDV hijacks the host apoptotic effector Caspase-3 to dismantle the IRF7-mediated antiviral defense, thereby facilitating viral immune evasion and replication. This study provides new insights into viral pathogenesis and suggests Caspase-3/IRF7 as potential therapeutic targets for IBDV control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.